OrbiMed Advisors III, Director: Terns Pharmaceuticals TERN Sell · Filed 24/07/17

Trade details

Type: Insider sale
Amount: $61,420
Shares · price: 6,142 sh · $10.00 a share
Held after: 756,258 sh
Stock: Terns Pharmaceuticals TERN
Person: OrbiMed Advisors IIIDirector
Trade date: 24/07/15
Filed: 24/07/17
Days to filing: 2 days

Sold 0.8% of holdings

Share of holding sold: 0.8%

Terns Pharmaceuticals trades, last 26 weeks

What else happened in Terns Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/06/15~24/08/14

OrbiMed Advisors III's recent trades

OrbiMed Advisors IIIDirector
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 plan
Terns Pharmaceuticals
TERN
$394.3K
39,433 sh
$394.3K
Filed 24/07/17
Traded 24/07/15
OrbiMed Advisors IIIDirector
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 plan
Terns Pharmaceuticals
TERN
$54K
5,401 sh
$54K
Filed 24/07/17
Traded 24/07/15
OrbiMed Advisors IIIDirector
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 plan
Terns Pharmaceuticals
TERN
$40.1K
4,009 sh
$40.1K
Filed 24/07/17
Traded 24/07/16
OrbiMed Advisors IIIDirector
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 plan
Terns Pharmaceuticals
TERN
$6,230
623 sh
$6,230
Filed 24/07/17
Traded 24/07/16
OrbiMed Advisors IIIDirector
Sell10b5-1 planTerns Pharmaceuticals
Sell10b5-1 plan
Terns Pharmaceuticals
TERN
$5,560
556 sh
$5,560
Filed 24/07/17
Traded 24/07/16